Outcomes with the “V” Implantation Technique vs. Standard Technique for Testosterone Pellet Therapy

Standard technique (ST) for implantation of testosterone pellets involves making a single linear track in the subcutaneous tissue of the buttock from the incision. After our initial experience with this modality, we modified this surgical technique to our current “V” technique (VT). This involves tw...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of sexual medicine 2011-12, Vol.8 (12), p.3465-3470
Hauptverfasser: Conners, William, Flinn, Kevin, Morgentaler, Abraham
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3470
container_issue 12
container_start_page 3465
container_title Journal of sexual medicine
container_volume 8
creator Conners, William
Flinn, Kevin
Morgentaler, Abraham
description Standard technique (ST) for implantation of testosterone pellets involves making a single linear track in the subcutaneous tissue of the buttock from the incision. After our initial experience with this modality, we modified this surgical technique to our current “V” technique (VT). This involves two tracks both caudally directed and emanating from the same skin incision but angulated approximately 10–15 degrees apart. While this allows additional pellets to be inserted more easily, and increased space to place those pellets further from the skin incision, it minimally increases the surgical procedure. We sought to examine the impact of this technical modification on therapeutic efficacy and surgical complication rates. Retrospective chart review of all patients treated with testosterone pellets at our institution. Complication rates for infection, extrusion, hematoma, and pain. One hundred sixty‐eight patients underwent 281 implantation procedures (40 via ST and 241 via VT). The mode number of pellets used with ST was 8 (range 6–8) and with VT was 10 (range 10–13). Incidence of pellet extrusion was 7.5% with ST and 0.8% with VT. Infection complicated ST in 5% of cases but only 1.2% with VT. No cases of hematoma were seen with ST but 1.2% of VT cases. Pain prompting discontinuation of therapy was seen in 7.5% with ST and 1.7% with VT. Significant pain without discontinuation was seen in 5% with ST and 1.2% with VT. Only in 1 of the 3 cases of hematoma was the individual on blood thinners. Fifty‐eight other insertions were performed on blood thinners without significant hematoma. None of the individuals who developed infection or bleeding required additional surgical therapy. VT allows successful placement of larger number of pellets, with low rates of complications, especially extrusion, even in men on anticoagulants. Conners W, Flinn K, and Morgentaler A. Outcomes with the “V” implantation technique vs. standard technique for testosterone pellet therapy. J Sex Med **;**:**–**.
doi_str_mv 10.1111/j.1743-6109.2011.02441.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_908011316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1743609515333609</els_id><sourcerecordid>908011316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4651-876935e43825e2a176aaf77581715397ab5794c4a166677d0ff7379c0dc77af63</originalsourceid><addsrcrecordid>eNqNkMFy0zAQhjUMDC2FV2B042QjWbJkHzhAC6VMaMs0wFGjymuiYFtBUtrk1geBl-uTIOM2ww32ol3p_1e7H0KYkpymeLnMqeQsE5TUeUEozUnBOc03D9D-7uHhfU7qcg89CWFJCEtRPEZ7Ba0qVnO-j76draNxPQR8beMCxwXg25ufX25vfuGTftXpIepo3YDnYBaD_bEGfBVyfBH10Gjf_HXdOp-qEF2I4N0A-By6DiKeL8Dr1fYpetTqLsCzu_MAfX73dn74PpudHZ8cvp5lhouSZpUUNSuBs6ooodBUCq1bKcuKSlqyWurLUtbccE2FEFI2pG0lk7UhjZFSt4IdoBdT35V3aawQVW-DSaPoAdw6qJpUiRejo7KalMa7EDy0auVtr_1WUaJGymqpRoBqhKlGyuoPZbVJ1ud3n6wve2h2xnusSfBqElzbDrb_3Vh9uPg4ZsmfTX6baG52fu2_K5H2LdXX02PFzufs00ycqqOkfzPpIaG9suBVMBYGA431YKJqnP33Vr8B6diw5w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>908011316</pqid></control><display><type>article</type><title>Outcomes with the “V” Implantation Technique vs. Standard Technique for Testosterone Pellet Therapy</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><source>Oxford Journals</source><creator>Conners, William ; Flinn, Kevin ; Morgentaler, Abraham</creator><creatorcontrib>Conners, William ; Flinn, Kevin ; Morgentaler, Abraham</creatorcontrib><description>Standard technique (ST) for implantation of testosterone pellets involves making a single linear track in the subcutaneous tissue of the buttock from the incision. After our initial experience with this modality, we modified this surgical technique to our current “V” technique (VT). This involves two tracks both caudally directed and emanating from the same skin incision but angulated approximately 10–15 degrees apart. While this allows additional pellets to be inserted more easily, and increased space to place those pellets further from the skin incision, it minimally increases the surgical procedure. We sought to examine the impact of this technical modification on therapeutic efficacy and surgical complication rates. Retrospective chart review of all patients treated with testosterone pellets at our institution. Complication rates for infection, extrusion, hematoma, and pain. One hundred sixty‐eight patients underwent 281 implantation procedures (40 via ST and 241 via VT). The mode number of pellets used with ST was 8 (range 6–8) and with VT was 10 (range 10–13). Incidence of pellet extrusion was 7.5% with ST and 0.8% with VT. Infection complicated ST in 5% of cases but only 1.2% with VT. No cases of hematoma were seen with ST but 1.2% of VT cases. Pain prompting discontinuation of therapy was seen in 7.5% with ST and 1.7% with VT. Significant pain without discontinuation was seen in 5% with ST and 1.2% with VT. Only in 1 of the 3 cases of hematoma was the individual on blood thinners. Fifty‐eight other insertions were performed on blood thinners without significant hematoma. None of the individuals who developed infection or bleeding required additional surgical therapy. VT allows successful placement of larger number of pellets, with low rates of complications, especially extrusion, even in men on anticoagulants. Conners W, Flinn K, and Morgentaler A. Outcomes with the “V” implantation technique vs. standard technique for testosterone pellet therapy. J Sex Med **;**:**–**.</description><identifier>ISSN: 1743-6095</identifier><identifier>EISSN: 1743-6109</identifier><identifier>DOI: 10.1111/j.1743-6109.2011.02441.x</identifier><identifier>PMID: 21883944</identifier><language>eng</language><publisher>Malden, USA: Elsevier Inc</publisher><subject>Androgens - administration &amp; dosage ; Androgens - adverse effects ; Androgens - therapeutic use ; Drug Implants - administration &amp; dosage ; Humans ; Hypogonadism ; Hypogonadism - drug therapy ; Infusions, Subcutaneous ; Male ; Middle Aged ; Outcomes ; Retrospective Studies ; Statistics as Topic ; Subcutaneous Testosterone Pellet Implant ; Testopel ; Testosterone ; Testosterone - administration &amp; dosage ; Testosterone - adverse effects ; Testosterone - therapeutic use ; Treatment Outcome</subject><ispartof>Journal of sexual medicine, 2011-12, Vol.8 (12), p.3465-3470</ispartof><rights>2011 International Society for Sexual Medicine</rights><rights>2011 International Society for Sexual Medicine.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4651-876935e43825e2a176aaf77581715397ab5794c4a166677d0ff7379c0dc77af63</citedby><cites>FETCH-LOGICAL-c4651-876935e43825e2a176aaf77581715397ab5794c4a166677d0ff7379c0dc77af63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1743-6109.2011.02441.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1743-6109.2011.02441.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21883944$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Conners, William</creatorcontrib><creatorcontrib>Flinn, Kevin</creatorcontrib><creatorcontrib>Morgentaler, Abraham</creatorcontrib><title>Outcomes with the “V” Implantation Technique vs. Standard Technique for Testosterone Pellet Therapy</title><title>Journal of sexual medicine</title><addtitle>J Sex Med</addtitle><description>Standard technique (ST) for implantation of testosterone pellets involves making a single linear track in the subcutaneous tissue of the buttock from the incision. After our initial experience with this modality, we modified this surgical technique to our current “V” technique (VT). This involves two tracks both caudally directed and emanating from the same skin incision but angulated approximately 10–15 degrees apart. While this allows additional pellets to be inserted more easily, and increased space to place those pellets further from the skin incision, it minimally increases the surgical procedure. We sought to examine the impact of this technical modification on therapeutic efficacy and surgical complication rates. Retrospective chart review of all patients treated with testosterone pellets at our institution. Complication rates for infection, extrusion, hematoma, and pain. One hundred sixty‐eight patients underwent 281 implantation procedures (40 via ST and 241 via VT). The mode number of pellets used with ST was 8 (range 6–8) and with VT was 10 (range 10–13). Incidence of pellet extrusion was 7.5% with ST and 0.8% with VT. Infection complicated ST in 5% of cases but only 1.2% with VT. No cases of hematoma were seen with ST but 1.2% of VT cases. Pain prompting discontinuation of therapy was seen in 7.5% with ST and 1.7% with VT. Significant pain without discontinuation was seen in 5% with ST and 1.2% with VT. Only in 1 of the 3 cases of hematoma was the individual on blood thinners. Fifty‐eight other insertions were performed on blood thinners without significant hematoma. None of the individuals who developed infection or bleeding required additional surgical therapy. VT allows successful placement of larger number of pellets, with low rates of complications, especially extrusion, even in men on anticoagulants. Conners W, Flinn K, and Morgentaler A. Outcomes with the “V” implantation technique vs. standard technique for testosterone pellet therapy. J Sex Med **;**:**–**.</description><subject>Androgens - administration &amp; dosage</subject><subject>Androgens - adverse effects</subject><subject>Androgens - therapeutic use</subject><subject>Drug Implants - administration &amp; dosage</subject><subject>Humans</subject><subject>Hypogonadism</subject><subject>Hypogonadism - drug therapy</subject><subject>Infusions, Subcutaneous</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Outcomes</subject><subject>Retrospective Studies</subject><subject>Statistics as Topic</subject><subject>Subcutaneous Testosterone Pellet Implant</subject><subject>Testopel</subject><subject>Testosterone</subject><subject>Testosterone - administration &amp; dosage</subject><subject>Testosterone - adverse effects</subject><subject>Testosterone - therapeutic use</subject><subject>Treatment Outcome</subject><issn>1743-6095</issn><issn>1743-6109</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMFy0zAQhjUMDC2FV2B042QjWbJkHzhAC6VMaMs0wFGjymuiYFtBUtrk1geBl-uTIOM2ww32ol3p_1e7H0KYkpymeLnMqeQsE5TUeUEozUnBOc03D9D-7uHhfU7qcg89CWFJCEtRPEZ7Ba0qVnO-j76draNxPQR8beMCxwXg25ufX25vfuGTftXpIepo3YDnYBaD_bEGfBVyfBH10Gjf_HXdOp-qEF2I4N0A-By6DiKeL8Dr1fYpetTqLsCzu_MAfX73dn74PpudHZ8cvp5lhouSZpUUNSuBs6ooodBUCq1bKcuKSlqyWurLUtbccE2FEFI2pG0lk7UhjZFSt4IdoBdT35V3aawQVW-DSaPoAdw6qJpUiRejo7KalMa7EDy0auVtr_1WUaJGymqpRoBqhKlGyuoPZbVJ1ud3n6wve2h2xnusSfBqElzbDrb_3Vh9uPg4ZsmfTX6baG52fu2_K5H2LdXX02PFzufs00ycqqOkfzPpIaG9suBVMBYGA431YKJqnP33Vr8B6diw5w</recordid><startdate>201112</startdate><enddate>201112</enddate><creator>Conners, William</creator><creator>Flinn, Kevin</creator><creator>Morgentaler, Abraham</creator><general>Elsevier Inc</general><general>Blackwell Publishing Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201112</creationdate><title>Outcomes with the “V” Implantation Technique vs. Standard Technique for Testosterone Pellet Therapy</title><author>Conners, William ; Flinn, Kevin ; Morgentaler, Abraham</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4651-876935e43825e2a176aaf77581715397ab5794c4a166677d0ff7379c0dc77af63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Androgens - administration &amp; dosage</topic><topic>Androgens - adverse effects</topic><topic>Androgens - therapeutic use</topic><topic>Drug Implants - administration &amp; dosage</topic><topic>Humans</topic><topic>Hypogonadism</topic><topic>Hypogonadism - drug therapy</topic><topic>Infusions, Subcutaneous</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Outcomes</topic><topic>Retrospective Studies</topic><topic>Statistics as Topic</topic><topic>Subcutaneous Testosterone Pellet Implant</topic><topic>Testopel</topic><topic>Testosterone</topic><topic>Testosterone - administration &amp; dosage</topic><topic>Testosterone - adverse effects</topic><topic>Testosterone - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Conners, William</creatorcontrib><creatorcontrib>Flinn, Kevin</creatorcontrib><creatorcontrib>Morgentaler, Abraham</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of sexual medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Conners, William</au><au>Flinn, Kevin</au><au>Morgentaler, Abraham</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes with the “V” Implantation Technique vs. Standard Technique for Testosterone Pellet Therapy</atitle><jtitle>Journal of sexual medicine</jtitle><addtitle>J Sex Med</addtitle><date>2011-12</date><risdate>2011</risdate><volume>8</volume><issue>12</issue><spage>3465</spage><epage>3470</epage><pages>3465-3470</pages><issn>1743-6095</issn><eissn>1743-6109</eissn><abstract>Standard technique (ST) for implantation of testosterone pellets involves making a single linear track in the subcutaneous tissue of the buttock from the incision. After our initial experience with this modality, we modified this surgical technique to our current “V” technique (VT). This involves two tracks both caudally directed and emanating from the same skin incision but angulated approximately 10–15 degrees apart. While this allows additional pellets to be inserted more easily, and increased space to place those pellets further from the skin incision, it minimally increases the surgical procedure. We sought to examine the impact of this technical modification on therapeutic efficacy and surgical complication rates. Retrospective chart review of all patients treated with testosterone pellets at our institution. Complication rates for infection, extrusion, hematoma, and pain. One hundred sixty‐eight patients underwent 281 implantation procedures (40 via ST and 241 via VT). The mode number of pellets used with ST was 8 (range 6–8) and with VT was 10 (range 10–13). Incidence of pellet extrusion was 7.5% with ST and 0.8% with VT. Infection complicated ST in 5% of cases but only 1.2% with VT. No cases of hematoma were seen with ST but 1.2% of VT cases. Pain prompting discontinuation of therapy was seen in 7.5% with ST and 1.7% with VT. Significant pain without discontinuation was seen in 5% with ST and 1.2% with VT. Only in 1 of the 3 cases of hematoma was the individual on blood thinners. Fifty‐eight other insertions were performed on blood thinners without significant hematoma. None of the individuals who developed infection or bleeding required additional surgical therapy. VT allows successful placement of larger number of pellets, with low rates of complications, especially extrusion, even in men on anticoagulants. Conners W, Flinn K, and Morgentaler A. Outcomes with the “V” implantation technique vs. standard technique for testosterone pellet therapy. J Sex Med **;**:**–**.</abstract><cop>Malden, USA</cop><pub>Elsevier Inc</pub><pmid>21883944</pmid><doi>10.1111/j.1743-6109.2011.02441.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1743-6095
ispartof Journal of sexual medicine, 2011-12, Vol.8 (12), p.3465-3470
issn 1743-6095
1743-6109
language eng
recordid cdi_proquest_miscellaneous_908011316
source MEDLINE; Wiley Online Library Journals; Oxford Journals
subjects Androgens - administration & dosage
Androgens - adverse effects
Androgens - therapeutic use
Drug Implants - administration & dosage
Humans
Hypogonadism
Hypogonadism - drug therapy
Infusions, Subcutaneous
Male
Middle Aged
Outcomes
Retrospective Studies
Statistics as Topic
Subcutaneous Testosterone Pellet Implant
Testopel
Testosterone
Testosterone - administration & dosage
Testosterone - adverse effects
Testosterone - therapeutic use
Treatment Outcome
title Outcomes with the “V” Implantation Technique vs. Standard Technique for Testosterone Pellet Therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T15%3A11%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20with%20the%20%E2%80%9CV%E2%80%9D%20Implantation%20Technique%20vs.%20Standard%20Technique%20for%20Testosterone%20Pellet%20Therapy&rft.jtitle=Journal%20of%20sexual%20medicine&rft.au=Conners,%20William&rft.date=2011-12&rft.volume=8&rft.issue=12&rft.spage=3465&rft.epage=3470&rft.pages=3465-3470&rft.issn=1743-6095&rft.eissn=1743-6109&rft_id=info:doi/10.1111/j.1743-6109.2011.02441.x&rft_dat=%3Cproquest_cross%3E908011316%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=908011316&rft_id=info:pmid/21883944&rft_els_id=S1743609515333609&rfr_iscdi=true